v3.25.2
INTERIM CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($)
$ in Millions
Total
Total
Issued capital
Capital Surplus
Other capital reserves
Accumulated deficit
Foreign currency translation
Non- controlling interests
Number of shares outstanding at beginning of period (in shares) at Dec. 31, 2023     1,755,964,785          
Equity at beginning of period at Dec. 31, 2023 $ 1,071 $ 858 $ 2 $ 12,753 $ (1,968) $ (3,939) $ (5,990) $ 213
Profit for the period 167 125       125   42
Other comprehensive loss (82) (80)     (6) (2) (72) (2)
Total comprehensive income / (loss) 85 45     (6) 123 (72) 40
Dividends declared (39)             (39)
Other (in shares)     10,354,070          
Other 1 1     2 (1)    
Number of shares outstanding at end of period (in shares) at Jun. 30, 2024     1,766,318,855          
Equity at end of period at Jun. 30, 2024 1,118 904 $ 2 12,753 (1,972) (3,817) (6,062) 214
Number of shares outstanding at beginning of period (in shares) at Mar. 31, 2024     1,755,964,785          
Equity at beginning of period at Mar. 31, 2024 1,133 896 $ 2 12,753 (1,966) (3,882) (6,011) 237
Profit for the period 89 68       68   21
Other comprehensive loss (62) (57)     (3) (3) (51) (5)
Total comprehensive income / (loss) 27 11     (3) 65 (51) 16
Dividends declared (39)             (39)
Other (in shares)     10,354,070          
Other (3) (3)     (3)      
Number of shares outstanding at end of period (in shares) at Jun. 30, 2024     1,766,318,855          
Equity at end of period at Jun. 30, 2024 1,118 904 $ 2 12,753 (1,972) (3,817) (6,062) 214
Number of shares outstanding at beginning of period (in shares) at Dec. 31, 2024     1,765,484,059          
Equity at beginning of period at Dec. 31, 2024 1,257 1,099 $ 2 12,753 (1,953) (3,530) (6,173) 158
Profit for the period 726 694       694   32
Transfer from OCI to income statement on disposal of subsidiary (454) (454)         (454)  
Other comprehensive income / (loss) 16 16     7   9  
Other comprehensive loss (438)              
Total comprehensive income / (loss) 288 256     7 694 (445) 32
Share repurchases (in shares)     (36,639,125)          
Share repurchases (68) (68)     (68)      
Other 19 19     19      
Number of shares outstanding at end of period (in shares) at Jun. 30, 2025     1,728,844,934          
Equity at end of period at Jun. 30, 2025 1,496 1,306 $ 2 12,753 (1,995) (2,836) (6,618) 190
Number of shares outstanding at beginning of period (in shares) at Mar. 31, 2025     1,752,489,609          
Equity at beginning of period at Mar. 31, 2025 1,388 1,207 $ 2 12,753 (1,967) (3,431) (6,150) 181
Profit for the period 608 595       595   13
Transfer from OCI to income statement on disposal of subsidiary (454) (454)         (454)  
Other comprehensive income / (loss) (10) (6)     8   (14) (4)
Other comprehensive loss (464)              
Total comprehensive income / (loss) 144 135     8 595 (468) 9
Share repurchases (in shares)     (23,644,675)          
Share repurchases (44) (44)     (44)      
Other 8 8     8      
Number of shares outstanding at end of period (in shares) at Jun. 30, 2025     1,728,844,934          
Equity at end of period at Jun. 30, 2025 $ 1,496 $ 1,306 $ 2 $ 12,753 $ (1,995) $ (2,836) $ (6,618) $ 190